---
$id: https://graph.org.ai/products/commodity/51112525
$type: Product
source: UNSPSC
code: "51112525"
title: "Trofosfamide"
class: "51112500"
classTitle: "Alkylating agent nitrogen mustard compounds"
family: "51110000"
familyTitle: "Antineoplastic agents"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Trofosfamide

**UNSPSC Code**: 51112525
**Class**: [Alkylating agent nitrogen mustard compounds](Alkylating agent nitrogen mustard compounds.mdx)
**Family**: [Antineoplastic agents](../Antineoplastic agents.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a nitrogen mustard compound with the molecular formula C9H18Cl3N2O2P, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier H64JRU6GJ0, chemically known as 3-(2-chloroethyl)-2-(bis(2-chloroethyl)amino)tetrahydro-2h-1,3,2-oxazaphosphorin 2-oxide but more generally known as trofosfamide, which bears US NIH Compound Identifier 65702. European Medicines Agency schedules Trofosfamide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB11331MIG. The term TROFOSFAMIDE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 24, No. 11 1970, List 10). World Health Organization schedules trofosfamide in its Anatomical Therapeutic Chemical (ATC) Classification. TROFOSFAMIDE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations, for tariff and trade purposes, schedule trofosfamide under HS 29349990 and SITC 51579. As of Q4 2014, TROFOSFAMIDE remains US FDA's Preferred Term for this commodity. Trofosfamide bears US NLM identifiers UMLS ID C0077375 and NCI Concept Code C1268. SMILES: CLCCN1P(=O)(OCCC1)N(CCCL)CCCL.

